Patents Assigned to Euro-Diagnostica AB
  • Patent number: 9322828
    Abstract: The invention relates to monoclonal antibodies which are reactive with an epitope in the polypeptide represented by amino acid sequence 236 to 251 or 264 to 279 of the human CGA amino acid sequence. The invention further relates to the use of these monoclonal antibodies in an immunoassay for CGA, to immunoreagents comprising any of these two antibodies, and to test kits for the determination of CGA containing immunoreagents based on both of the monoclonal antibodies.
    Type: Grant
    Filed: April 28, 2011
    Date of Patent: April 26, 2016
    Assignee: Euro-Diagnostica AB
    Inventors: Mats Stridsberg, Yngve Sommarin
  • Patent number: 8835119
    Abstract: The invention refers to an in vitro method of functionally determining at physiological conditions deficiencies in the lectin pathway of the complement system, the method comprising the steps of (a) providing a sample of mammalian blood, serum, plasma or another body fluid; (b) preventing in the sample the activation of the classical pathway by contacting the sample with an inhibitor of a molecule of the C1 complex of the complement system; (e) preventing in the sample the activation of the alternative pathway; (d) activating the lectin pathway in the sample; and (e) determining in the sample any activation of the autologous C5b-9 complex.
    Type: Grant
    Filed: July 11, 2003
    Date of Patent: September 16, 2014
    Assignee: Euro Diagnostica AB
    Inventors: Johanna Roos, Mohamed R. Daha, Lee H. Bouwman, Cornelis Erik Hack
  • Publication number: 20130084585
    Abstract: The invention relates to monoclonal antibodies which are reactive with an epitope in the polypeptide represented by amino acid sequence 236 to 251 or 264 to 279 of the human CGA amino acid sequence. The invention further relates to the use of these monoclonal antibodies in an immunoassay for CGA, to immunoreagents comprising any of these two antibodies, and to test kits for the determination of CGA containing immunoreagents based on both of the monoclonal antibodies.
    Type: Application
    Filed: April 28, 2011
    Publication date: April 4, 2013
    Applicant: EURO-DIAGNOSTICA AB
    Inventors: Mats Stridsberg, Yngve Sommarin
  • Publication number: 20100291705
    Abstract: An antigen exposing micelle or unordered aggregate comprising at least one carrier, at least one epitope and at least one anchoring molecule, wherein said anchoring molecule comprises at least one anchoring part, intended to anchor the antigen exposing micelle to a surface.
    Type: Application
    Filed: July 10, 2008
    Publication date: November 18, 2010
    Applicant: EURO-DIAGNOSTICA AB
    Inventors: Laura Varas, Anna Ketelsen, Hakan Eriksson
  • Patent number: 5989548
    Abstract: Pharmaceutical compositions comprising an antigenic amount of peptides derived from the L1 and L2 OFR's of human papillomavirus type 16 coupled to a carrier or in multimer form.
    Type: Grant
    Filed: December 18, 1997
    Date of Patent: November 23, 1999
    Assignee: Euro-Diagnostica AB
    Inventor: Joakim Dillner
  • Patent number: 5932412
    Abstract: The invention refer to a method for diagnosing the presence of infection of papilloma virus (PV) and of papilloma virus (PV) carrying, especially cervix cancer and condyloma, by the detection of virus specific antigen-antibody complexes in immunossay.
    Type: Grant
    Filed: September 22, 1997
    Date of Patent: August 3, 1999
    Assignee: Euro-Diagnostica AB
    Inventors: Joakim Dillner, Lena Dillner, Hwee-Ming Cheng